Position in LLY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$11,002,257,162
+$2,518,821,112 QoQ
Shares Held
9,172,904
-0.5% QoQ
Ownership
0.974%
of shares outstanding
% of Portfolio
6.51%
of 13F equity value
Holder Rank
#18
of 4,621 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 98%
Shared 0%
None 2%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026PRIMECAP MANAGEMENT CO/CA/ holds $23,952,609,496 across 9 Drug Manufacturers - General names. LLY ranks #1 (45.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
9,172,904 | $11,002,257,162 | |
| 2 | AZN |
Astrazeneca PLC
|
18,095,178 | $3,431,207,652 | |
| 3 | BIIB |
Biogen Inc.
|
15,154,606 | $3,274,304,172 | |
| 4 | AMGN |
Amgen Inc
|
6,756,962 | $2,446,831,079 | |
| 5 | BMY |
Bristol Myers Squibb Co
|
24,923,900 | $1,436,115,118 | |
| 6 | GSK |
GSK plc
|
25,182,068 | $1,320,044,004 | |
| 7 | NVS |
Novartis AG
|
6,592,124 | $1,033,117,673 | |
| 8 | MRK |
Merck & Co., Inc.
|
35,700 | $4,587,450 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $11,002,257,162 | 9,172,904 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $8,483,436,050 | 9,223,432 | Shares | Sole | 2026-05-11 | |
| 2025-12-31 | $9,957,751,526 | 9,265,782 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $8,236,842,894 | 10,795,338 | Shares | Sole | 2025-11-12 | |
| 2025-06-30 | $9,475,115,433 | 12,154,908 | Shares | Sole | 2025-08-11 | |
| 2025-03-31 | $12,206,759,840 | 14,779,770 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $12,936,136,888 | 16,756,654 | Shares | Sole | 2025-02-10 | |
| 2024-09-30 | $15,672,728,657 | 17,690,508 | Shares | Sole | 2024-11-08 | |
| 2024-06-30 | $17,761,819,081 | 19,618,082 | Shares | Sole | 2024-08-09 | |
| 2024-03-31 | $16,534,909,652 | 21,254,190 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $12,941,135,279 | 22,200,534 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $12,388,117,091 | 23,063,536 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $11,042,697,344 | 23,546,201 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $8,711,724,021 | 25,367,550 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $9,472,338,426 | 25,892,025 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $9,059,347,069 | 28,017,155 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $9,220,610,964 | 28,438,488 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $8,268,427,161 | 28,873,231 | Shares | Sole | 2022-05-11 | |
| 2021-12-31 | $8,201,159,905 | 29,690,681 | Shares | Sole | 2022-02-11 | |
| 2021-09-30 | $7,555,562,815 | 32,700,986 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $7,794,330,961 | 33,959,267 | Shares | Sole | 2021-08-10 | |
| 2021-03-31 | $6,609,361,862 | 35,378,235 | Shares | Sole | 2021-05-14 | |
| 2020-12-31 | $6,206,083,115 | 36,757,185 | Shares | Sole | 2021-02-08 | |
| 2020-09-30 | $5,621,107,458 | 37,975,324 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $6,506,117,980 | 39,627,957 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $5,817,265,093 | 41,935,302 | Shares | Sole | 2020-05-14 | |
| No filing history on record for this holder in this stock. | ||||||